Authors

Omar A. Al-Rawas

Publications 9

Research article Open access

Metered-dose inhaler technique among healthcare providers practising in Oman

Sawsan A. Baddar, Omar A. Al-Rawas, Kassim A. Worthing et al. · Sultan Qaboos University Medical Journal · 2025 · 10.18295/2075-0528.2578

Objective: To evaluate the correctness of metered-dose inhaler (MDI) technique in a sample of healthcare providers practicing in Oman, considering that poor inhaler technique is a common problem both in asthma patients and healthcare providers, which contributes to poor asthma control. Method: A total of 150 healthcare …

Research article Open access

Atopy in Omani patients with asthma

Maha Al-Amri, Omar A. Al-Rawas, Bazdawi MS Richens et al. · Sultan Qaboos University Medical Journal · 2025 · 10.18295/2075-0528.2593

Objectives: To determine the range of serum IgE in healthy subjects and in asthmatic patients in Oman and to assess the degree of atopy in the asthmatic patients. Method: Serum IgE and in vivo (the skin prick test) and in vitro (the ImmunoCAP test) allergen- specific IgE levels were measured in 44 patients with asthma. …

Research article Open access

The Pattern of Sensitisation to Inhalant Allergens in Omani Patients with Asthma, Allergic Rhinitis and Rhinoconjunctivitis

Salem H. Al-Tamemi, Azza N. Al-Shidhani, Rashid K. Jothi et al. · Sultan Qaboos University Medical Journal · 2025 · 10.18295/2075-0528.2742

Objective: Identification of relevant allergens that are prevalent in each environment which may have diagnostic and therapeutic implications in allergic diseases. This study aimed to identify the pattern of sensitisation to inhalant allergens in Omani patients with asthma, allergic rhinitis and rhinoconjunctivitis. Me …

Research article Open access

Regional Variation in the Prevalence of Asthma Symptoms among Omani School Children: Comparisons from Two Nationwide Cross-sectional Surveys Six Years Apart

Omar A. Al-Rawas, Bazdawi M. Al-Riyami, Hussein Al-Maniri et al. · Sultan Qaboos University Medical Journal · 2025 · 10.18295/2075-0528.2712

Objectives:The International Study of Asthma and Allergies in Children (ISAAC) highlighted the presence of wide variations in asthma prevalence between and within countries. The aim of this study was to determine the changes in the prevalence of asthma and its symptoms across the different regions of Oman. Methods: Two …

Research article Open access

Management and Control of Asthma in Patients Attending a Specialist Centre in Oman

Omar A. Al-Rawas, Jayakrishnan B, Fatma Ben George et al. · Sultan Qaboos University Medical Journal · 2025 · 10.18295/2075-0528.2779

Objectives: The management of asthma by specialists is likely to become more evidence-based. This study analysed the characteristics of patients reporting to a specialist clinic including demographics, dispensed medications and the level of asthma control. Methods: All consecutive stable asthmatics seen in the adult pu …

Research article Open access

Documentation of the Management of Asthma Exacerbation in Adults by Primary Health Care Physicians in a Teaching Hospital in Oman

Sawsan A. Baddar, Aida I. Al-Ismaili, Muna A. Al-Mahrezi et al. · Sultan Qaboos University Medical Journal · 2025 · 10.18295/2075-0528.1214

Objectives: Asthma exacerbation is a major cause of morbidity and it is usually an indication of poor control. Appropriate management and documentation of the clinical assessment of an exacerbation, its severity,contributing factors and treatment are all essential components of asthma control. The aim of this study was …

Research article Open access

Severe Pulmonary Involvement in Leptospirosis: Alternate antibiotics and systemic steroids

Jayakrishnan B, Fatma Ben Abid, Abdullah Al-Kaabi et al. · Sultan Qaboos University Medical Journal · 2025 · 10.18295/2075-0528.1474

Pulmonary complications in leptospirosis, though common, are often unrecognized in a non-endemic area. We report here a patient with leptospirosis and severe pulmonary involvement who was treated with meropenem (1 g every 8 hours), moxifloxacin (400 mg once daily), and high doses of corticosteroids. Systemic steroids w …

Co-authors